« Return to News | CROs/Service Providers | Study Conduct

Russia's clinical trials are a thriving business

Friday, March 18, 2011 01:31 PM

ClinStar, a CRO providing clinical research services in Russia and Eastern Europe, discussed the benefits of conducting clinical trials in Russia in an interview with NPR Marketplace health desk reporter Gregory Warner.

Warner reported the clinical trial industry in Russia is growing by 15%. ClinStar president and CEO David Passov said the advantages of clinical trials in Russia is the ability for biopharmaceutical companies to enroll patients three to 20 times faster than in North America and Western Europe.

Passov said, “The clinical trial industry has been well established in North America and Western Europe for the last 25 years or so now. For many who are not familiar with clinical trials and the drug development process, Russia is considered to be an emerging region for clinical trial conduct. By most definitions, however, Russia is not an emerging country for clinical trials but rather a well established country for conducting clinical research.”

“In an era where the costs to develop a drug are greater than $1 billion, and only an estimated one in 5,000 compounds ever make it to market, the benefits of conducting clinical trials in Russia are too great to ignore,” said executive director of business development and marketing Erin King. “By speeding up the patient enrollment process, biopharmaceutical companies are able to shrink the clinical trial timeline and reduce the overall costs to get a drug approved.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.